Monday, November 2, 2026

When Dreams Turn Violent: The Reality of REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) can cause physical actions during dreams, leading to injuries and potential links to dementia.

How PARKIE and STAN Are Transforming Parking and Logistics in Asia: A Comprehensive Guide

HL Robotics is launching autonomous parking robots PARKIE and STAN to enhance parking and logistics automation services.

RLWRLD Appoints Carl Choi as U.S. Head: What This Means for AI Robotics in 2026

RLWRLD appoints Carl Choi as U.S. representative to enhance market entry and partnerships in AI and robotics sectors.

Health

Leading Fertility Experts to Gather in Busan as Patients Seek Answers on Treatment Options

International reproductive immunology experts will gather in Busan to discuss the causes and treatment of infertility, with three public forums giving patients and families an opportunity to ask specialists directly about repeated IVF failures, recurrent miscarriages and possible treatment approaches.

Daewoong Pharmaceutical Targets Global Market With Long-Acting Injection and Patch Technologies

Daewoong Pharmaceutical is pursuing global opportunities with three next-generation drug delivery platforms designed for long-acting injections, microneedle patches and highly concentrated biologic formulations.

PRBom and MSD Korea Place Third in Global PR Awards for HPV Prevention Campaign

A decade-long campaign by PRBom and MSD Korea to raise awareness of HPV prevention has placed third in the 2026 Global SABRE Awards, standing out as the only South Korean campaign among the 40 finalists.

Celltrion Pharm Launches Prefilled-Syringe Version of Yuflyma in South Korea, Strengthening Price Competitiveness

Celltrion Pharm has launched a safety-equipped prefilled-syringe version of its Humira biosimilar Yuflyma in South Korea, expanding treatment options while offering one of the lowest prices among products containing the same active ingredient.

Konkuk University Medical Team Surpasses 6,000 Microvascular Decompression Surgeries

A neurosurgery team at Konkuk University Medical Center has performed more than 6,000 microvascular decompression procedures to treat hemifacial spasm and trigeminal neuralgia, a milestone achieved by few medical teams worldwide.

Hugel holds first regional symposium in Beijing, to tour key cities including Shanghai and Guangzhou

Hugel held a successful symposium in Beijing to enhance awareness of its Letybo product among Chinese medical professionals.

2026 PRP Kit Revolution: How Humedix and Medisarang Are Transforming Regenerative Medicine

Humedics and Medisarang partner to develop regenerative medicine devices, focusing on PRP kits for aesthetics and other medical fields.

Revolutionizing Patient Care: How thynC™ AI is Transforming Hospital Monitoring in 2026

ThynC technology enhances patient monitoring at Dongtan City Hospital, improving care efficiency and safety through real-time data analysis.

Celltrion sees prescription growth for key products in Europe, raises expectations for high-margin new drugs

Celltrion's cancer and autoimmune disease treatments are achieving stable growth in Europe, expanding their market influence.

Coreline Soft Secures Major AI Contract with Italy’s National Cancer Center for Lung Cancer Early Detection

Coreline Soft renews its contract for AVIEW LCS Plus with Italy's National Cancer Center, enhancing early lung cancer diagnosis via AI.

SCL Healthcare secures patent for technology predicting metabolic syndrome using 3cc of blood

SCL Healthcare has patented a DNA methylation technology to predict metabolic syndrome risk, enhancing disease diagnosis from blood samples.

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

Unlock Healthier Hair: JW Shinyak’s Ducray Neoptide Expert Shows 93.6% User Satisfaction in Global Study

JW Shinyak's Ducray Neoptide Expert shows significant hair improvement in a global trial, with high user satisfaction across ages and conditions.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

Unlocking Weight Loss: How GB102 Probiotics Enhance GLP-1 Obesity Drugs

GI Longevity's GB102 probiotic enhances weight loss with GLP-1 medications, reducing rebound gain and improving blood sugar control.

YH35995: A Game-Changer for Gaucher Disease? FDA Grants Orphan Drug Designation

Yuhan Corp's YH35995 for Gaucher disease receives orphan drug designation, enhancing its development for rare diseases with unmet needs.

Neurophet Unveils AI-Powered Alzheimer’s Treatment Software at ITEM 2026 in Japan

Neurophet showcases AI-driven brain disease tech at ITEM 2026 in Japan, partnering with Hokuyaku Takeyama to expand market reach.

AI vs. Traditional Methods: Discover the Game-Changing Clinical Environment Simulator for Medical Evaluations

A new Clinical Environment Simulator (CES) evaluates medical AI in realistic settings, enhancing safety without risking patient lives.

Pet7 Launches Innovative Probiotic: A Comprehensive Guide for Dog Owners

Cha Bio F&C launches Pet7 Gut Care Probiotics to enhance canine digestive health with a blend of probiotics, prebiotics, and enzymes.

Top News

- Our Sponsors Ad -

Follow us